Extracorporeal immune therapy with immobilized agonistic anti-Fas antibodies leads to transient reduction of circulating neutrophil numbers and limits tissue damage after hemorrhagic shock/resuscitation in a porcine model
© Lögters et al; licensee BioMed Central Ltd. 2010
Received: 6 August 2009
Accepted: 20 April 2010
Published: 20 April 2010
Hemorrhagic shock/resuscitation is associated with aberrant neutrophil activation and organ failure. This experimental porcine study was done to evaluate the effects of Fas-directed extracorporeal immune therapy with a leukocyte inhibition module (LIM) on hemodynamics, neutrophil tissue infiltration, and tissue damage after hemorrhagic shock/resuscitation.
In a prospective controlled double-armed animal trial 24 Munich Mini Pigs (30.3 ± 3.3 kg) were rapidly haemorrhaged to reach a mean arterial pressure (MAP) of 35 ± 5 mmHg, maintained hypotensive for 45 minutes, and then were resuscitated with Ringer' solution to baseline MAP. With beginning of resuscitation 12 pigs underwent extracorporeal immune therapy for 3 hours (LIM group) and 12 pigs were resuscitated according to standard medical care (SMC). Haemodynamics, haematologic, metabolic, and organ specific damage parameters were monitored. Neutrophil infiltration was analyzed histologically after 48 and 72 hours. Lipid peroxidation and apoptosis were specifically determined in lung, bowel, and liver.
In the LIM group, neutrophil counts were reduced versus SMC during extracorporeal immune therapy. After 72 hours, the haemodynamic parameters MAP and cardiac output (CO) were significantly better in the LIM group. Histological analyses showed reduction of shock-related neutrophil tissue infiltration in the LIM group, especially in the lungs. Lower amounts of apoptotic cells and lipid peroxidation were found in organs after LIM treatment.
Transient Fas-directed extracorporeal immune therapy may protect from posthemorrhagic neutrophil tissue infiltration and tissue damage.
Hemorrhagic shock is a leading cause of complications and death in combat casualties and civilian trauma . It has been shown to cause systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), and multiple organ failure (MOF) . Despite intensive investigations, the pathophysiology of posthemorrhagic multiple organ failure remains incompletely understood. Recently, it has been reported that neutrophils recruited by mitochondrial products (formyl peptides and mitochondrial DNA) released from damaged tissues and cells are responsible for the inflammation seen in SIRS . However, tissue infiltration with activated polymorphonuclear neutrophils is associated with collateral tissue damage elicited by excessive amounts of neutrophil-derived proteases and oxygen radicals which may affect all major organs and largely contribute to MODS [4–17].
One major reason for the collateral damage mediated by hyperactivated neutrophils is the prolonged neutrophil survival time in conjunction with resistance against apoptosis . There is increasing evidence that prolonged neutrophil survival is due to reduced susceptibility to proapoptotic mediators as a result of proinflammatory cytokines  and cytokines . Moreover, intracellular inhibitors of apoptosis proteins (IAPs) are important regulators of neutrophil survival time under inflammatory conditions . Unfortunately, the role of modified neutrophil susceptibility against proapoptotic signaling in the posttraumatic/posthemorrhagic situation and its potential for therapeutic targeting is largely unknown.
Recently, we developed an extracorporeal immune therapy approach to inactivate circulating neutrophils by targeting neutrophil Fas [22–25]. It is known that adequate cross-linking of Fas (APO-1, CD95) on the neutrophil surface membrane stimulates proapoptotic signaling pathways [26, 27] but probably may also lead to cellular changes independent from apoptosis . In this regard, we could show earlier that neutrophils rapidly become inactive following contact with membrane bound FasL  or with immobilized agonistic anti-Fas IgM antibody . Moreover, evidence has been obtained that the transient contact of technetium-labelled neutrophils with immobilized anti-Fas IgM leads to their rapid sequestration in the spleen . This proposed mechanism might efficiently reduce the number of preapoptotic circulating neutrophils within the circulation. In addition, we recently showed that apoptosis resistance of hyperactivated neutrophils from patients with major trauma may be overcome by agonistic Fas stimulation  which may also lead to a shorter life time of activated circulating neutrophils.
This experimental study was done to find out whether neutrophil Fas-directed extracorporeal immune therapy may limit posthemorrhagic inflammation and MODS. Therefore, an extracorporeal mini circuit was developed for the use in a porcine hemorrhagic shock model. As the functional unit, a down-scaled adaptation of the anti-Fas containing leukocyte inhibition module (LIM) as it was used previously for the integration in heart-lung machines  was connected to the circuit. The module allows Fas specific inactivation of circulating neutrophils at a flow of 300 ml/min. At this flow neutrophils adhere to and roll over biofunctionally modified three dimensional polyurethane surfaces that carry covalently immobilized anti-Fas (anti-CD95) monoclonal IgM antibodies. Upon contact with the biofunctional surface, inactivated neutrophils rapidly lose their ability to adhere and to migrate towards chemotactic signals [12, 29]. Consequently, neutrophils detach from the artificial surface and may be efficiently cleared from the blood probably by phagocytic engulfment  and degradation in the spleen .
To define whether this specific extracorporeal immune therapy is superior over standard medical care, one group of animals was hemorrhaged/resuscitated without any further treatment whereas the verum group underwent posthemorrhagic extracorporeal immune therapy with the mini-circuit.
Animals and groups
The animal experiments were performed according to the National Institutes of Health Guidelines for the use of experimental animals. This study was approved by the regional government of Düsseldorf and supervised by the animal health officer of the University of Düsseldorf. Twenty-four pigs (Munich mini pigs; 30.3 ± 3.3 kg) were allocated to 2 groups (each n = 12). All animals were fasted 24 hours before surgery and only received water ad libitum. For histological control samples five additional untreated healthy animals were sacrificed.
Premedication and anesthesia
The animals were premedicated with ketamine and azaperon. Pigs were anesthetized with analgosedation (Thiopental), relaxed, and intubated endotracheally. Ventilation was performed with Isoflurane (1%) and nitrous oxide:oxygen (3:1) mixture with a tidal volume adjusted to maintain PaCO2 values between 36 and 44 Torr [4.8 and 5.9 kPa] and PaO2 between 100 and 150 Torr [13.3 and 20 kPa].
All invasive procedures were accomplished using aseptic technique. Several catheters were inserted for hemodynamic monitoring, blood sampling and connection of the circuits for LIM. A median cut at the ventral neck was accomplished to allow insertion of a 5-Fr catheter into the left carotid artery for continuous arterial pressure monitoring. An 8-Fr Sheldon catheter was placed into the left external jugular vein. This catheter was used for controlled hemorrhage, extracorporeal circulation, and intermittent blood sampling. In addition an 8-Fr introducer sheath was placed into the right external jugular vein followed by a Swan-Ganz catheter (Edwards Lifesciences, Irvine, California, USA) insertion. After verifying proper calibration of arterial and Swan-Ganz-catheter all catheters were fixed subcutaneously.
Extracorporeal Fas-targeted immune therapy with the Leukocyte inhibition module (LIM)
All animals were allowed to equilibrate for 15 minutes before baseline measurements (time point 0; Figure 1B). After two additional baseline measurements within 10 minutes, each animal was hemorrhaged rapidly through the Sheldon catheter over 15 minutes in order to reach a mean arterial pressure (MAP) of 35 ± 5 mmHg. Average volume of withdrawn blood was 586 ± 22 ml (SMC: 555 ± 34 ml; LIM: 616 ± 26 ml, n.s.). All animals were kept hypotensive for the next 30 minutes at an MAP of 35 ± 5 mmHg and for further 15 minutes at 40 ± 5 mmHg.
Subsequently, resuscitation was carried out by transfusion of 961 ± 28 ml crystalloid (Ringer') solution back to about 90% of the baseline MAP level (SMC: 916 ± 50 ml; LIM: 1005 ± 18 ml, n.s.). Fifteen minutes after resuscitation extracorporeal circuits were connected to the Sheldon catheter and extracorporeal circulation was initiated with a flow rate of 300 ml/min (LIM group, n = 12). After 3 hours the circuit was flushed with Ringer's solution and disconnected. All animals were then allowed to recover and observed for 48 hours (n = 12, 6 of each group) or 72 hours (n = 12, 6 of each group). Then animals underwent anesthesia, intubation and ventilation again. Catheters were reconnected and after a steady-state stabilization period of 30 minutes hemodynamic parameters were examined for 15 minutes. Finally, pigs were sacrificed and autopsy was performed.
During anesthesia following hemodynamic variables were continuously measured with Swan-Ganz and arterial catheter: mean arterial pressure (MAP), heart rate (HR), cardiac output (CO), central venous pressure (CVP), pulmonary capillary wedge pressure (PCWP), mean pulmonary arterial pressure (MPAP), and central venous oxygen saturation (svO2). Blood gas samples were collected every 10 minutes throughout the experimental procedure and measured with a blood gas analysis system (ABL800 Flex, Radiometer GmbH, Willich, Germany). From beginning of baseline measurements venous blood samples were collected at time points 10, 25, 70, 85, 95, 115, 145, 205, 265 minutes as well 12, 24, 48, 72 h after surgery and were analyzed with standardized methods of clinical chemistry. Red blood count, leukocyte count and differential, erythrocyte parameters and platelets were analyzed from EDTA blood (scil animal care company GmbH, Viernheim, Germany).
Histology and staining procedures
All animals included in this study as well as five healthy control animals without any treatment have been euthanised in order to harvest organs for histological evaluation. Tissue samples were fixed in 4% formaldehyde and embedded in paraffin according to standard procedures. Sections (5 μm) were stained with hematoxylin-eosin for pathological examination. In addition, chloracetatesterase staining was performed for specific detection and quantification of tissue infiltration by neutrophils. Neutrophils were counted in a blinded and standardized fashion by microscopy (Axiovert 40, Zeiss, Jena, Germany). Briefly, an ocular micrometer (x10) was used to count neutrophils in 10 different high power fields (HPF) of each section. Mean values from each organ and animal were allocated to predefined ranges of countings/0.09 mm2 (0-5, 6-10, 11-20, 21-50, 51-100, 101-500).
Quantification of apoptotic cells in tissue sections by TUNEL - Assay
For histological evaluation of apoptotic cells in the porcine tissues, tissue samples of lung, liver, and bowel were frozen directly after removal in liquid nitrogen and stored at -80°C before further utilization. For Tdt-mediated dUTP Nick-End Labeling (TUNEL)-Assay, samples were first embedded in paraffin and 5 μm - sections were prepared according to standard protocols. All following steps were done according to instructions of DeadEnd™ Fluorometric TUNEL System kit (Promega GmbH, Mannheim, Germany). Microscopic examination of DAPI (4'-6-Diamidin-2'-phenylindol-dihydrochlorid) stained nuclei and apoptotic domains was carried out with a fluorescence microscope (Axioskop 40, Zeiss, Jena, Germany) in 400 fold magnification. Different visual fields were selected for each tissue type to count up to 1000 DAPI positive cells. The percentage of apoptotic cells was calculated as the number of TUNEL positive cells from all DAPI positive cells counted. As a positive control for the staining procedure some slides were incubated with DNase before TUNEL staining, resulting in 100% TUNEL positive cells in each field.
Polymerase chain reaction
Total RNA from tissue was extracted using TRI REAGENT (Sigma, Munich, Germany) according to the manufacturer's instructions. 10 μl of total RNA was reverse transcribed using oligo (dT) 15 primer (Sigma, Munich, Germany), employing Omniscript Reverse Transcriptase (Qiagen, Hilden, Germany) and following the manufacturer's instructions. PCR was carried out using gene specific primer sequences for heme oxygenase-1 (HO-1; pHO-1-R: 5'-CGTAGCGCTTGGTGGCCTGCG-3'; -F: 5'-CAGCCCAACAGCATGCCCCAG-3', Genosys-Sigma, Munich, Germany). Primers for glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (hGAPDH-R: 5'-GAAGTCAGAGGAGACCACCA-3'; -F: 5'-CACCACCATGGAGAAGGCTG-3', Genosys-Sigma, Munich, Germany) were used as controls. 2.5 μl of cDNA were amplified using Taq PCR Core Kit (Qiagen, Hilden, Germany) and products were separated on 1.8% agarose gel and visualized under UV after Sybr Gold (Invitrogen, Karlsruhe, Germany) staining.
Western blot analysis
Tissue samples were suspended in RIPA buffer (1% Nonidet-P40 (NP40), 0.5 mM sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS) in PBS) supplemented with the Complete Protease Inhibitor Cocktail (Roche, Mannheim, Germany). Samples were sonicated and incubated at 4°C for 15 min. After centrifugation at 8,000 × g for 10 min and 4°C, protein concentration was assayed using the Dc Protein Assay kit from Bio-Rad. Protein (30 μg/sample) was separated on SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose membrane. Membranes were saturated in Tris-buffered saline (TBS) containing 0.1% Tween-20 and 5% w/v nonfat dry milk (blocking buffer) for 60 min at room temperature and then incubated with mouse HO-1 monoclonal primary antibodies specific against pig HO-1 (Stressgen, Victoria, Canada) diluted in TBS containing 0.1% Tween-20 and 5% w/v nonfat dry milk. After three washes in TBS containing 0.1% Tween-20, the membranes were incubated for 60 min at room temperature with the horseradish peroxidase-labelled polyclonal goat anti-mouse secondary antibody for HO-1 (Dako Cytomation, Glostrup, Denmark), diluted 1:1,000 in TBS, 0.1% Tween-20 and washed as described above. Bands were visualized by the enhanced chemiluminescence method (SuperSignal West pico Chemiluminescent Substrate, Pierce, Bonn, Germany). Equal loading of gels was confirmed both by Ponceau S staining of membranes and by re-incubation of the filters with a polyclonal antibody for beta-Actin (Santa Cruz, Heidelberg, Germany). The amount of specific protein was quantified by densitometry (Quantity One, Bio-Rad, Munich, Germany).
Lipid peroxidation assay
The determination of lipid peroxidation in tissue homogenates was done by quantification of thiobarbituric acid reactive substances (TBARS; Cayman Chemical Company, Ann Arbor, MI). Lipid peroxides, derived from polyunsaturated fatty acids, are unstable and decompose to form a complex series of compounds, which include reactive carbonyl compounds, such as malondialdehyde (MDA). The assay is based on the reaction of MDA with thiobarbituric acid (TBA) which is added to the sample. MDA-TBA adducts formed by the reaction of MDA and TBA under high temperature (90-100°C) and acidic conditions is measured colorimetrically at 530-540 nm (Victor 3, Perkin Elmer). Briefly, 25 mg of frozen tissue (-80°C) were mixed with RIPA buffer (1% Nonidet-P40 (NP40), 0.5 mM sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS) in PBS) with protease inhibitors (Complete Mini, Roche). The mixture was homogenized with a pestle and sonicated (Ultrasonic processor UP50H, Hielscher) for 15 seconds on ice. The tubes were then centrifuged at 1600 × g for 10 minutes at 4°C. The supernatant was used for protein concentration analysis (Dc Protein Assay, Biorad), standarized at 1 mg protein/ml solution and utilized for TBARS-assay immediately. The assay was done in duplicates in 96 well plates. Data were compared with standards provided by the manufacturer. The obtained MDA values were calculated using the formula provided by the manufacturer. The dynamic range of the kit is 0-50 μM MDA equivalents.
Statistical analysis was carried out using the SAS/Stat for Windows software (SAS Institute, Inc, Cary, NC, version 8) and SPSS (SPSS, Inc, Chicago, IL, version 15). Non-parametric tests of the raw data were used to analyze specific inter-group and over-time differences. Data was considered to be statistically significant at p < 0.05. Wilcoxon two-sample test was used for specific inter-group (LIM versus SMC groups) difference and Wilcoxon paired test for over time differences (time point versus start value).
Effects of LIM on leukocyte counts
Effects of LIM on hemodynamics
Time kinetics of hemodynamic parameters
75.7 ± 2.57
75.2 ± 3.11
44.9 ± 2.64 a
40.3 ± 4.86 a
43.8 ± 2.63 a
52.9 ± 2.54 ab
86.7 ± 3.41
96.2 ± 4.37
91.9 ± 6.59
105.9 ± 6.63
95.6 ± 9.77
90.0 ± 5.00
3.0 ± 0.13
3.1 ± 0.12
2.3 ± 0.23
2.3 ± 0.30
2.2 ± 0.08 a
3.1 ± 0.24 b
3.3 ± 0.70
3.8 ± 0.55
1.1 ± 0.69
5.8 ± 2.19 b
3.4 ± 1.70
4.8 ± 1.24
86.9 ± 0.95
82.9 ± 2.69
56.0 ± 2.47 a
57.7 ± 6.44 a
49.1 ± 3.70 a
63.1 ± 5.77
7.3 ± 1.23
8.2 ± 0.57
3.8 ± 0.88
5.2 ± 0.89
5.9 ± 1.43
5.9 ± 1.12
14.8 ± 1.22
17.8 ± 1.49
7.3 ± 1.01 a
10.9 ± 1.10 ab
12.2 ± 2.10 a
13.7 ± 1.05 a
Ischemia and tissue damage parameters
Time kinetics of metabolic and organ specific parameters
3.3 ± 0.26
3.4 ± 0.38
3.4 ± 0.28
4.0 ± 0.43 a
2.1 ± 0.39
2.4 ± 0.78
2.3 ± 0.22 a
1.6 ± 0.31 a
3.1 ± 0.58
5.0 ± 0.57 b
1.4 ± 0.91
1.4 ± 0.71 a
4.3 ± 0.58
4.8 ± 1.59
5.2 ± 0.92
6.1 ± 1.05
1.0 ± 0.03
0.9 ± 0.05 b
1.0 ± 0.05
0.9 ± 0.06
1.2 ± 0.07 a
1.2 ± 0.16
0.9 ± 0.09
1.1 ± 0.18
1.1 ± 0.06
0.8 ± 0.04 b
56 ± 6.8
40 ± 2.8
37 ± 4 a
31 ± 2.91
912 ± 193 a
1853 ± 572 a
378 ± 120 a
854 ± 515 a
62 ± 6.8
64 ± 9.7
60 ± 5.68
51.1 ± 3.0
31 ± 3.3 a
26 ± 1.28 a
203 ± 25.3 a
258 ± 33.8 a
178 ± 19.2 a
213 ± 30.0 a
108 ± 5.84 a
123 ± 16.5 a
1643 ± 220
1183 ± 87
982 ± 134 a
716 ± 56 a
58420 ± 9767 a
77653 ± 14960 a
15851 ± 4185 a
29439 ± 15529 a
2338 ± 233
1431 ± 305 b
180 ± 20
151 ± 6
95 ± 13 a
97 ± 10 a
767 ± 84 a
969 ± 144 a
294 ± 33
467 ± 152 a
156 ± 12 a
134 ± 31
Troponin T [< 0.05]
0.03 ± 0.01
0.02 ± 0.003
0.04 ± 0.01
0.04 ± 0.01 a
0.08 ± 0.03
0.15 ± 0.05 a
0.02 ± 0.004
0.04 ± 0.021
0.02 ± 0.006
0.01 ± 0.00
Neutrophil tissue infiltration
HO-1 expression, lipid peroxidation, and apoptosis
The putative contribution of apoptosis within bowels, lungs, and livers was studied by TUNEL staining. The numbers of TUNEL positive cells as the percentage from DAPI positive cells were calculated. Results are depicted as relative countings (Figure 6B) and qualitatively as microphotographs (Figure 6C). Apoptosis was lower in the lamina propria of the bowels (p < 0.05) and in the lungs (not significant) of animals in the LIM group compared with the SMC group. No Apoptosis was found by TUNEL staining in the liver.
In our porcine hemorrhagic shock/resuscitation model we observed impaired hemodynamics, neutrophil tissue infiltration, lipid peroxidation in the bowel, lung, and liver during an observation period of 72 hours Extracorporeal immune therapy targeting neutrophil Fas ameliorated shock-related pathophysiology. The ability of the mouse-anti-human agonistic anti-Fas IgM used in this study to induce porcine neutrophil apoptosis and to impair the effector functions was shown in earlier studies [22, 25]. In previous experiments and in experiments that were done to establish this model, mini circuits without antibody coating were run to exclude effects mediated by the circuit itself. In these tests hemodynamics and leukocyte counts were similar to the SMC group. However, in the current study we may not totally exclude LIM effects that are not dependent on Fas activation on neutrophils.
Our working hypothesis was that posthemorrhagic targeting of circulating neutrophil Fas may rapidly impair neutrophil effector functions and thus may prevent their prolonged hyperactivation and neutrophil-mediated tissue damage. We previously found that binding of neutrophils to membrane-bound but not soluble FasL inactivated neutrophils within minutes even before signs of apoptosis were detectable , leading us to the assumption that immobilized agonistic anti-Fas may be used to therapeutically limit hyperactivation of neutrophils. In addition, functionalized biocompatible surfaces with agonistic anti-Fas in extracorporeal immune therapy may be more suitable than systemic application of anti-Fas because the latter approach has been shown to have severe side effects such as liver toxicity and pulmonary fibrosis [32, 33].
Therefore, in order to effectively inactivate neutrophils in an early phase of posthemorrhagic immune deregulation, an extracorporeal circuit with a neutrophil inhibition module (LIM) on the functional basis of immobilized agonistic anti-Fas IgM was used in a porcine hemorrhagic shock/resuscitation model. The proof of concept of such an approach had been previously shown in patients undergoing cardiac surgery [24, 25].
In this study, the efficacy of LIM has been shown by the relative reduction of neutrophil counts during the treatment phase. Histopathological analyses of post hemorrhagic organs clearly revealed lower numbers of neutrophils within the pulmonary tissues and slightly less numbers in heart, liver, kidney and bowel in animals of the LIM group versus SMC. In addition, we found evidence of improved pulmonary, cardiac, and kidney function in the LIM group as indicated by partially higher svO2, and better cardiac output, respectively. Moreover, CK values were lower in the LIM group, however, only after 72 hours. Due to high SEM values at 24 and 48 hours, the interpretation of these data has to be done carefully. Overall, the obtained evidence that posthemorrhagic hemodynamics and metabolism may be better in the LIM group versus SMC should be confirmed by future studies. In addition, the unexpected reduction of monocyte counts by LIM treatment requires further studies.
Although controversial reports exist regarding activation or inhibition of different cell types by Fas stimulation  we never observed increased activity upon challenging neutrophils ex vivo with immobilized agonistic Fas. One possible mechanistic explanation of our findings from this in vivo study may be that LIM treatment impairs the motility of circulating neutrophils which may partly result in the failure of neutrophils to transmigrate into tissues. Consequently, the well known neutrophil-mediated disruption of the integrity of endothelial/epithelial layers, impairment of microcirculation, induction of oxidative stress with subsequent lipid peroxidation [35, 36] might be limited by LIM. Indeed, neutrophil chemotactic activity has been shown previously to be reduced after LIM treatment . It has been shown previously that blood cells made apoptotic by extracellular exposure to psoralen and UV light exerted anti-inflammatory effects in a graft-versus-host disease model . It would be of interest to find out whether similar anti-inflammatory mechanisms may also exist upon Fas-mediated neutrophil apoptosis. Further evidence that apoptotic cells have anti-inflammatory and immunosuppressive effects when given systemically in a model of murine LPS-induced endotoxic shock has been reported .
Herein, shock/resuscitation-induced hemoxygenase-1 (HO-1) expression, probably as a consequence of posthemorrhagic oxidative stress [39, 40], was clearly limited in the LIM group in lung, liver, and bowel, organs that frequently are impaired after trauma . HO-1 is known to be induced by oxidative stress and has been shown by others to protect from hemorrhagic shock-induced tissue injury . The finding that gene and protein expression of HO-1 was found to be lower in the LIM group may be a result of limited neutrophil infiltration and neutrophil-mediated oxidative stress.
Shock-induced lipid peroxidation was only observed in the bowels. However, there seems to be no direct correlation between the amount of lipid peroxidation and infiltrated neutrophils within the bowel since only low neutrophil numbers could be detected in the bowel after shock. In contrast, high numbers of apoptotic cells were found in the lamina propria of the bowel in the SMC but not in the LIM group suggesting that inhibition of peripheral inhibition of circulating neutrophils during posthemorrhagic inflammation may result in protection of the bowel. Similarly, shock-induced apoptosis in the lung tissue was also largely prevented by LIM. The underlying mechanisms remain to be defined. One possible explanation might be that LIM protects from the previously described no-reflow phenomenon associated with neutrophils that are sequestered in the capillaries of the tissues, thus damaging the tissue in the absence of overt neutrophil tissue infiltration .
From our data we conclude that targeting of neutrophil Fas during the early posthemorrhagic or posttraumatic time period may ameliorate inflammation-mediated sequelae and thus may be of therapeutic benefit for trauma patients. Due to the small sample size the conclusions have to be made carefully. As usual for explorative studies that have the main objective in the identification of the best primary end point for subsequent confirmative studies, multiple testing of different parameters and time points had to be done, resulting in a reduction of the robustness of the tests performed. Nevertheless, the results obtained provide an interesting basis encouraging further evaluation.
However, the timing of neutrophil inhibition has to be critically considered since inhibition of neutrophil activation might impair anti bacterial phagocytic effects of neutrophils which are essential to prevent sepsis [42, 43]. On the other hand, the early prevention of neutrophil-mediated disruption e.g. of the intestinal or pulmonary epithelium might in turn prevent bacterial dissemination and sepsis. Further studies investigating potential clinical benefits of neutrophil Fas-directed immune therapy in patients after hemorrhagic shock or severe trauma are encouraged.
This study relied on financial resources of the University of Düsseldorf. It was partly supported by the German "Bundesministerium für Wirtschaft" (ProInno) and the Deutsche Forschungsgemeinschaft (SCHO-612/3-1). The authors thank Samira Seghrouchni and Jutta Schneider for the excellent technical assistance.
- Moore FA, McKinley BA, Moore EE: The next generation in shock resuscitation. Lancet. 2004, 363: 1988-1996. 10.1016/S0140-6736(04)16415-5.PubMedView ArticleGoogle Scholar
- Baue AE, Durham R, Faist E: Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle?. Shock. 1998, 10: 79-89. 10.1097/00024382-199808000-00001.PubMedView ArticleGoogle Scholar
- Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, Hauser CJ: Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010, 464: 104-107. 10.1038/nature08780.PubMedPubMed CentralView ArticleGoogle Scholar
- Bone RC: Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit Care Med. 1996, 24: 163-172. 10.1097/00003246-199601000-00026.PubMedView ArticleGoogle Scholar
- Brown KA, Brain SD, Pearson JD, Edgeworth JD, Kewis SM, Treacher DF: Neutrophils in development of multiple organ failure in sepsis. Lancet. 2006, 368: 157-169. 10.1016/S0140-6736(06)69005-3.PubMedView ArticleGoogle Scholar
- Fan J, Li Y, Levy RM, Fan JJ, Hackam DJ, Vodovotz Y, Yang H, Tracey KJ, Billiar TR, Wilson MA: Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: role of HMGB1-TLR4 signaling. J Immunol. 2007, 178: 6573-6580.PubMedView ArticleGoogle Scholar
- Hoesel LM, Neff TA, Neff SB, Younger JG, Olle EW, Gao H, Pianko MJ, Bernacki KD, Sarma JV, Ward PA: Harmful and protective roles of neutrophils in sepsis. Shock. 2005, 24: 40-47. 10.1097/01.shk.0000170353.80318.d5.PubMedView ArticleGoogle Scholar
- Lenz A, Franklin GA, Cheadle WG: Systemic inflammation after trauma. Injury. 2007, 38: 1336-1345. 10.1016/j.injury.2007.10.003.PubMedView ArticleGoogle Scholar
- Scholz M, Cinatl J, Schädel-Höpfner M, Windolf J: Neutrophils and the blood-brain barrier dysfunction after trauma. Med Res Rev. 2007, 27: 401-416. 10.1002/med.20064.PubMedView ArticleGoogle Scholar
- Shimizu T, Tani T, Endo Y, Hanasawa K, Tsuchiya M, Kodama M: Elevation of plasma peptidoglycan and peripheral blood neutrophil activation during hemorrhagic shock: plasma peptidoglycan reflects bacterial translocation and may affect neutrophil activation. Crit Care Med. 2002, 30: 77-82. 10.1097/00003246-200201000-00012.PubMedView ArticleGoogle Scholar
- Weiss SJ: Tissue destruction by neutrophils. N Engl J Med. 1989, 320: 365-276.PubMedView ArticleGoogle Scholar
- Wesche DE, Lomas-Neira JL, Perl M, Chung CS, Ayala A: Leukocyte apoptosis and its significance in sepsis and shock. J Leukoc Biol. 2005, 78: 325-337. 10.1189/jlb.0105017.PubMedView ArticleGoogle Scholar
- Roesner JP, Petzelbauer P, Koch A, Tran N, Iber T, Vagts DA, Scheeren TW, Vollmar B, Nöldge-Schomburg GE, Zacharowski K: Bbeta15-42 (FX06) reduces pulmonary, myocardial, liver, and small intestine damage in a pig model of hemorrhagic shock and reperfusion. Crit Care Med. 2009, 37: 598-605. 10.1097/CCM.0b013e3181959a12.PubMedView ArticleGoogle Scholar
- Mori T, Yamamoto H, Tabata T, Shimizu T, Endo Y, Hanasawa K, Fujimiya M, Tani T: A free radical scavenger, edaravone (MCI-186), diminishes intestinal neutrophil lipid peroxidation and bacterial translocation in a rat hemorrhagic shock model. Crit Care Med. 2005, 33: 1064-1069. 10.1097/01.CCM.0000162952.14590.EC.PubMedView ArticleGoogle Scholar
- Thorburn K: Bacterial translocation and intestinal neutrophil lipid peroxidation in a hemorrhagic shock model--Rat race or rat trap?. Crit Care Med. 2005, 33: 1167-1169. 10.1097/01.CCM.0000162914.50682.AC.PubMedView ArticleGoogle Scholar
- Toda Y, Takahashi T, Maeshima K, Shimizu H, Inoue K, Morimatsu H, Omori E, Takeuchi M, Akagi R, Morita K: A neutrophil elastase inhibitor, sivelestat, ameliorates lung injury after hemorrhagic shock in rats. Int J Mol Med. 2007, 19: 237-243.PubMedGoogle Scholar
- Zakaria el R, Campbell JE, Peyton JC, Garrison RN: Postresuscitation tissue neutrophil infiltration is time-dependent and organ-specific. J Surg Res. 2007, 143: 119-125. 10.1016/j.jss.2007.04.008.PubMedPubMed CentralView ArticleGoogle Scholar
- Simon H-U: Neutrophil apoptosis pathways and their modifications in inflammation. Immunological Reviews. 2003, 193: 101-110. 10.1034/j.1600-065X.2003.00038.x.PubMedView ArticleGoogle Scholar
- Casatella MA: Neutrophil-derived proteins: selling cytokines by the pound. Adv Immunol. 1999, 73: 369-509. full_text.View ArticleGoogle Scholar
- Dibbert B, Weber M, Nikolaizik WH, Vogt P, Schöni MH, Blaser K, Simon HU: Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosis: a general mechanism to accumulate effector cells in inflammation. Proc Natl Acad Sci USA. 1999, 96: 13330-13335. 10.1073/pnas.96.23.13330.PubMedPubMed CentralView ArticleGoogle Scholar
- Saba S, Soong G, Greenberg S, Prince A: Bacterial stimulation of epithelial G-CSF and GM-CSF expression promotes PMN survival in CF airways. Am J Respir Cell Mol Biol. 2002, 27: 561-567.PubMedView ArticleGoogle Scholar
- Abdel-Rahman U, Margraf S, Aybek T, Loegters T, Moreno JB, Francischetti I, Kranert T, Gruenwald F, Windolf J, Moritz A, Scholz M: Inhibition of neutrophil activity improves cardiac function after cardiopulmonary bypass. J Inflamm. 2007, 4: 21-29. 10.1186/1476-9255-4-21.View ArticleGoogle Scholar
- Scholz M, Cinatl J: Fas/FasL interaction: A novel immune therapy approach with immobilized biologicals. Med Res Rev. 2005, 25: 331-342. 10.1002/med.20025.PubMedView ArticleGoogle Scholar
- Scholz M, Cinatl J, Barros RT, Lisboa AC, Genevcius CF, Margraf S, Francischetti I, Oremek G, Windolf J, Simon A, Moritz A, Bitu-Moreno J: First efficacy and safety results with the antibody containing leukocyte inhibition module in cardiac surgery patients with neutrophil hyperactivity. ASAIO J. 2005, 51: 144-147. 10.1097/01.MAT.0000153646.20861.DE.PubMedView ArticleGoogle Scholar
- Scholz M, Simon A, Berg M, Schuller AM, Hacibayramoglu M, Margraf S, Theisen A, Windolf J, Wimmer-Greinecker G, Moritz A: In vivo inhibition of neutrophil activity by a FAS (CD95) stimulation module: Arterial in-line application in a porcine cardiac surgery model. J Thorac Cardiovasc Surg. 2004, 127: 1735-1742. 10.1016/j.jtcvs.2003.09.027.PubMedView ArticleGoogle Scholar
- Salmen S, Teran G, Borges L, Goncalvez L, Albarran B, Urdaneta H, Montes H, Berrueta L: Increased Fas-mediated apoptosis in pölymorphonuclear cells from HIV-infected patients. Clin Exp Immunol. 2004, 137: 166-172. 10.1111/j.1365-2249.2004.02503.x.PubMedPubMed CentralView ArticleGoogle Scholar
- Ayub K, Laffafian I, Dewitt S, Hallett MB: Ca influx shutdown in neutrophils induced by Fas (CD95) cross-linking. Immunology. 2004, 112: 454-460. 10.1111/j.1365-2567.2004.01899.x.PubMedPubMed CentralView ArticleGoogle Scholar
- Peter ME, Budd RC, Desbarats J, Hedrick SM, Hueber AO, Newell MK, Owen LB, Pope RM, Tschopp J, Wajant H, Wallach D, Wiltrout RH, Zörnig M, Lynch DH: The CD95 receptor: apoptosis revisited. Cell. 2007, 129: 447-450. 10.1016/j.cell.2007.04.031.PubMedView ArticleGoogle Scholar
- Cinatl J, Blaheta R, Bittoova M, Scholz M, Margraf S, Vogel JU, Cinatl J, Doerr HW: Decreased neutrophil adhesion to human cytomegalovirus-infected retinal pigment epithelial cells is mediated by virus-induced up-regulation of Fas ligand independent of neutrophil apoptosis. J Immunol. 2000, 165: 4405-4413.PubMedView ArticleGoogle Scholar
- Paunel-Görgülü A, Zörnig M, Lögters T, Altrichter J, Rabenhorst U, Cinatl J, Windolf J, Scholz M: Mcl-1-mediated impairment of the intrinsic apoptosis pathway in circulating neutrophils from critically ill patients can be overcome by Fas stimulation. J Immunol. 2009, 183: 6198-206. 10.4049/jimmunol.0901264.PubMedView ArticleGoogle Scholar
- Cox G, Crossley J, Xing Z: Macrophage engulfment of apoptotic neutrophils contributes to the resolution of acute pulmonary inflammation in vivo. Am J Respir Cell Mol Biol. 1995, 12: 232-237.PubMedView ArticleGoogle Scholar
- Chang B, Nishikawa M, Sato E, Inoue M: Mice lacking inducible nitric oxide synthase show strong resistance to anti-Fas antibody-induced fulminant hepatitis. Arch Biochem Biophys. 2003, 411: 63-72. 10.1016/S0003-9861(02)00723-3.PubMedView ArticleGoogle Scholar
- Hagimoto N, Kuwano K, Miyazaki H, Kunitake R, Fujita M, Kawasaki M, Kaneko Y, Hara N: Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of Fas antigen. Am J Respir Cell Mol Biol. 1997, 17: 272-278.PubMedView ArticleGoogle Scholar
- Strasser A, Jost PJ, Nagata S: The many roles of FAS receptor signaling in the immune system. Immunity. 2009, 30: 180-192. 10.1016/j.immuni.2009.01.001.PubMedPubMed CentralView ArticleGoogle Scholar
- Schuller AM, Windolf J, Blaheta R, Cinatl J, Kreuter J, Wimmer-Greinecker G, Moritz A, Scholz M: Degradation of microvascular brain endothelial cell beta-catenin after co-culture with activated neutrophils from patients undergoing cardiac surgery with prolonged cardiopulmonary bypass. Biochem Biophys Res Commun. 2005, 329: 616-623. 10.1016/j.bbrc.2005.02.019.PubMedView ArticleGoogle Scholar
- Gatza E, Rogers CE, Clouthier SG, Lowler KP, Tawara I, Liu C, Reddy P, Ferrara JL: Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells. Blood. 2008, 112: 1515-1521. 10.1182/blood-2007-11-125542.PubMedPubMed CentralView ArticleGoogle Scholar
- Ren Y, Xie Y, Jiang G, Fan J, Yeung J, Li W, Tam PK, Savill J: Apoptotic cells protect mice against lipopolysaccharide-mediated shock. J Immunol. 2008, 180: 4978-4985.PubMedView ArticleGoogle Scholar
- Engler R, Covell JW: Granulocytes cause reperfusion ventricular dysfunction after 15 min ischaemia in the dog. Circ Res. 1987, 61: 20-28.PubMedView ArticleGoogle Scholar
- Rensing H, Jaeschke H, Bauer I, Pätau C, Datene V, Pannen BH, Bauer M: Differential activation pattern of redox-sensitive transcription factors and stress-inducible dilator systems heme oxygenase-1 and inducible nitric oxide synthase in hemorrhagic and endotoxic shock. Crit Care Med. 2001, 29: 1962-1971. 10.1097/00003246-200110000-00019.PubMedView ArticleGoogle Scholar
- Douzinas EE, Kollias S, Tiniakos D, Evangelou E, Papalois A, Rapidis AD, Tsoukalas GD, Patsouris E, Roussos C: Hypoxemic reperfusion after 120 mins of intestinal ischemia attenuates the histopathologic and inflammatory response. Crit Care Med. 2004, 32: 2279-2283.PubMedGoogle Scholar
- Engler R, Schmid-Schonbein GW, Pavelec R: Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol. 1983, 111: 98-111.PubMedPubMed CentralGoogle Scholar
- Maier B, Lefering R, Lehnert M, Laurer HL, Steudel WI, Neugebauer EA, Marzi I: Early versus late onset of multiple organ failure is associated with differing patterns of plasma cytokine biomarker expression and outcome after severe trauma. Shock. 2007, 28: 668-674.PubMedGoogle Scholar
- Sauer M, Altrichter J, Kreutzer HJ, Lögters T, Scholz M, Nöldge-Schomburg G, Schmidt R, Mitzner SR: Extracorporeal cell therapy with granulocytes in a pig model of Gram-positive sepsis. Crit Care Med. 2009, 37: 606-13. 10.1097/CCM.0b013e318194aa77.PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.